[go: up one dir, main page]

FR2885807B1 - Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation - Google Patents

Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation

Info

Publication number
FR2885807B1
FR2885807B1 FR0504997A FR0504997A FR2885807B1 FR 2885807 B1 FR2885807 B1 FR 2885807B1 FR 0504997 A FR0504997 A FR 0504997A FR 0504997 A FR0504997 A FR 0504997A FR 2885807 B1 FR2885807 B1 FR 2885807B1
Authority
FR
France
Prior art keywords
trimethoxybenzyl
piperazine
preparation
pharmaceutical composition
solid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0504997A
Other languages
English (en)
Other versions
FR2885807A1 (fr
Inventor
Jerome Besse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MG PHARMA
Original Assignee
MG PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MG PHARMA filed Critical MG PHARMA
Priority to FR0504997A priority Critical patent/FR2885807B1/fr
Priority to EP06709507A priority patent/EP1881831A1/fr
Priority to PCT/FR2006/050128 priority patent/WO2006123073A1/fr
Priority to EA200702386A priority patent/EA013645B1/ru
Priority to UAA200714180A priority patent/UA89408C2/ru
Publication of FR2885807A1 publication Critical patent/FR2885807A1/fr
Application granted granted Critical
Publication of FR2885807B1 publication Critical patent/FR2885807B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0504997A 2005-05-18 2005-05-18 Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation Expired - Lifetime FR2885807B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0504997A FR2885807B1 (fr) 2005-05-18 2005-05-18 Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation
EP06709507A EP1881831A1 (fr) 2005-05-18 2006-02-13 Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl)piperazine, et procede de preparation.
PCT/FR2006/050128 WO2006123073A1 (fr) 2005-05-18 2006-02-13 Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl)piperazine, et procede de preparation.
EA200702386A EA013645B1 (ru) 2005-05-18 2006-02-13 Твердая фармацевтическая композиция с пролонгированным высвобождением 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения
UAA200714180A UA89408C2 (ru) 2005-05-18 2006-02-13 Твердая фармацевтическая композиция пролонгированного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504997A FR2885807B1 (fr) 2005-05-18 2005-05-18 Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation

Publications (2)

Publication Number Publication Date
FR2885807A1 FR2885807A1 (fr) 2006-11-24
FR2885807B1 true FR2885807B1 (fr) 2008-05-16

Family

ID=35583424

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0504997A Expired - Lifetime FR2885807B1 (fr) 2005-05-18 2005-05-18 Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation

Country Status (5)

Country Link
EP (1) EP1881831A1 (fr)
EA (1) EA013645B1 (fr)
FR (1) FR2885807B1 (fr)
UA (1) UA89408C2 (fr)
WO (1) WO2006123073A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010084397A2 (fr) 2009-01-20 2010-07-29 Micro Labs Limited Compositions pharmaceutiques solides à libération modifiée à base de trimétazidine et procédé associé

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0815602A2 (pt) * 2007-08-08 2015-03-03 Usv Ltd Composições de liberação prolongada de trimetazidina e processo para a preparação das mesmas
EP2200591A2 (fr) * 2007-09-11 2010-06-30 Ranbaxy Laboratories Limited Formes galéniques à libération contrôlée à base de trimétazidine
TR201001902A2 (tr) * 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Uzatılmış salınımlı trimetazidin tablet
EP2394644B1 (fr) * 2010-05-04 2014-07-09 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Formulation de trimetazidine avec différents profils de distribution

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
DE60042972D1 (de) * 2000-10-05 2009-10-29 Usv Ltd Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
FR2818549B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine
WO2003043610A2 (fr) * 2001-11-21 2003-05-30 Themis Laboratories Private Limited Procede de fabrication d'une composition pharmaceutique a liberation prolongee contenant des microbilles de trimetazidine dihydrochloride

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010084397A2 (fr) 2009-01-20 2010-07-29 Micro Labs Limited Compositions pharmaceutiques solides à libération modifiée à base de trimétazidine et procédé associé

Also Published As

Publication number Publication date
EA013645B1 (ru) 2010-06-30
FR2885807A1 (fr) 2006-11-24
EA200702386A1 (ru) 2008-04-28
EP1881831A1 (fr) 2008-01-30
WO2006123073A1 (fr) 2006-11-23
UA89408C2 (ru) 2010-01-25

Similar Documents

Publication Publication Date Title
IL185562A (en) A method of preparing a pharmaceutical preparation containing stabilizer and microorganism
EP1748765A4 (fr) Suspension pharmaceutique
EP1425019A4 (fr) Composition pharmaceutique
ATE362771T1 (de) Pharmazeutische iressa zusammensetzung enthaltend ein wasserlösliches cellulosederivat
ATE460401T1 (de) 1,2,4,5-tetrahydro-3h-benzazepinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
HUP0500170A2 (en) Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
ATE397933T1 (de) Kristallinform gamma-d von ivabradine- hydrochlorid, verfahren zu dessen herstellung und diesen enthaltende pharmazeutische zusammensetzung
EP1954249A4 (fr) Machine et procede d'assemblage de produits pharmaceutiques et de produits de type pharmaceutique
DE602005015027D1 (de) Glucocorticoid-mimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und deren verwendung
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE337317T1 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen
EP1871347A4 (fr) Preparation pharmaceutique
ATE462408T1 (de) Pharmazeutische zusammensetzungen, enthaltend valatograst, und verfahren zu deren herstellung
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
EP2002828A4 (fr) Preparation pharmaceutique solide
EP1819323A4 (fr) Composition pharmaceutique renfermant un agent d'anti-nucleation
FR2885807B1 (fr) Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation
EP1867332A4 (fr) Composition pharmaceutique et procede d'utilisation d'un agent antifongique en combinaison
DE602005003453D1 (de) Neue effektor-konjugate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
ATE372992T1 (de) Indanyl-piperazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DK1750765T3 (da) Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
ATE381338T1 (de) Benzothiadiazinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen,die diese enthalten
ATE466863T1 (de) Neue aminopyrrolo-ä1,2-aü-indol- und aminopyridazino-ä1,6-aü-indol-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen damit
EP1937414A4 (fr) Forme pharmaceutique pour muqueuses orales

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13